Private equity firms Farallon Capital and Lauxera Capital led a $93m Series D round in LUMICKS, a supplier of medical equipment. Additional investors include Softbank Vision Fund 2, T. Rowe Price, Parian Global Management, Gilde Healthcare, Pura Vida Investments, and Irving Investors. "We are ecstatic to receive an investment from such an impressive group of investors that is excited to support us for our next phase of growth. The new investors are a wonderful complement to our existing investor base and bring an outstanding amount of industry knowledge that we believe will result in an incredibly positive partnership. With this fundraising, we believe LUMICKS is well positioned to drive significant growth of our Dynamic Single-Molecule platform and further accelerate the commercial adoption of the industry-changing z-Movi solution," Olivier Heyning, LUMICKS CEO.